Table 5.
Operative Outcomes After Mitral Valve Surgery
| Operative outcomes | Mitral surgery |
|---|---|
| Operative mortality, n (%) | 2 (4.5) |
| Length of mechanical ventilation, h (IQR) | 9.2 (4.0–51.0) |
| Intensive care unit length of stay, h (IQR) | 66.0 (24.0–139.7) |
| Hospital length of stay, d (IQR) | 10.6 (7.0–22.5) |
| Postoperative atrial fibrillation, n (%) | 15 (34.1) |
| Pneumonia, n (%) | 9 (20.4) |
| Renal failure, n (%) | 10 (22.7) |
| Delayed sternal closure, n (%) | 5 (11.3) |
| Gastrointestinal bleeding, n (%) | 4 (13.6) |
| Intra‐aortic balloon pump use, n (%) | 4 (9.1) |
| Sepsis, n (%) | 2 (4.5) |
| Extracorporeal membrane oxygenation use, n (%) | 2 (4.5) |
| Reexploration for surgical bleeding, n (%) | 1 (0.3) |
| Stroke, n (%) | 1 (0.3) |
IQR indicates interquartile range.